Acute Treatment of Migraine with Zolmitriptan 5mg Orally Disintegrating Tablet

Author： Egilius L.H. Spierings Alan M. Rapoport

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.15, 2004-01, pp. : 1133-1141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Zolmitriptan Oral Tablet in the Acute Treatment of Menstrual Migraine

By Tuchman Michael

CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. : 1019-1026

Adis International

Access to resources Recommend Favorite

Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine: A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study versus Zolmitriptan Tablet

By Charlesworth B.R.

CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. : 653-667

Adis International

Access to resources Recommend Favorite

Effectiveness and Satisfaction with Zolmitriptan 5mg Nasal Spray for Treatment of Migraine in Real-Life Practice: Results of a Postmarketing Surveillance Study

By Diener Hans-Christoph

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 59-66

Adis International

Access to resources Recommend Favorite

Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

By MacLennan S.J. Cambridge D. Whiting M.V. Marston C. Martin G.R.

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite